Watching multiple lung spots over time
Part of Lungs & breathing clinical trials.
This study is for people who have three or more tiny lung spots (called ground-glass nodules or GGNs) that have not changed in at least three months. The goal is to see if carefully monitoring these spots with regular CT scans is a safe and effective approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have three or more small spots (GGNs) in your lungs that have been stable for at least three months.
- The largest spot should be between 0.6 cm and 2 cm in size, and all spots should be mostly clear (not solid).
- You must be between 18 and 75 years old and in generally good health.
- You cannot have had any cancer treatment (like chemo or radiation) for these spots before.
- You cannot have had lung cancer or lung surgery in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether careful observation without immediate treatment is safe for people with small, stable lung nodules that look like ground-glass (hazy spots). If you join, the doctors will watch your nodules with regular CT scans to see if they change.
This Phase 2 trial studies whether a procedure called “ablation” is safe and effective for certain lung cancers that appear as ground-glass spots on CT scans and do not improve after 3 months. It may help people who cannot fully have surgery for their condition.
This study looks at whether different lymph node removal methods during lung surgery change outcomes for certain abnormal lung spots. It focuses on ground-glass nodules that stay the same after treatment-free observation and have a mostly solid portion on CT.
This study looks at whether people with a very early type of lung cancer can safely have curative surgery when their CT scan shows a ground-glass type spot with certain size and shape measurements. It aims to help doctors choose the right surgery approach based on the scan features and final pathology.
This trial compares two treatments for slow-growing lung spots (GGNs): freezing the spot (cryoablation) versus removing it with surgery. It's for people whose spots are small, not yet widespread, and who are able to have either procedure.
This study tests a new way to biopsy lung spots that appear as ground-glass opacities on CT scans. It uses a special microscope during bronchoscopy (a tube through the mouth into the lungs) to find the spot and then takes a tissue sample with a freezing probe. The goal is to get a more accurate diagnosis with fewer complications.
Hear when a new Active Surveillance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.